DarioHealth Corp. (DRIO) — Institutional Holders, Q2 2026
21 institutional investment managers reported a DRIO position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $5.7M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
DRIO in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- BlackRockAdded · +18,978 sh+$125.3K
- VANGUARD FIDUCIARYAdded · +7,317 sh+$48.3K
- CITADEL ADVISORSAdded · +3,829 sh+$25.3K
- MORGAN STANLEYAdded · +2,000 sh+$13.2K
- OSAICNew · +1,900 sh+$12.5K
Biggest sellers
- UBS Group AGTrimmed · -15,762 sh-$104.0K
- GEODE CAPITAL MANAGEMENTTrimmed · -3,843 sh-$25.4K
- Tower Research Capital (TRC)Sold out · -448 sh-$3.0K
- VANGUARD CAPITAL MANAGEMENTTrimmed · -235 sh-$1.6K
- SBI Securities , Ltd.Trimmed · -2 sh-$13.00
DRIO 13F holders ranked 1–21 of 21
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Nantahala Capital Management#1 · 610,691 sh | 610,691 | $4.0M | 0.13% | 0.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT#2 · 65,675 sh | 65,675 | $433.5K | 0.00% | -0.4% |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 58,035 sh | 58,035 | $383.3K | 0.00% | -6.2% |
| 4 | BlackRock#4 · 37,796 sh | 37,796 | $249.5K | 0.00% | +100.9% |
| 5 | VANGUARD FIDUCIARY#5 · 37,387 sh | 37,387 | $246.8K | <0.01% | +24.3% |
| 6 | CITADEL ADVISORS#6 · 24,289 sh | 24,289 | $160.3K | 0.00% | +18.7% |
| 7 | NORTHERN#7 · 13,237 sh | 13,237 | $87.4K | 0.00% | 0.0% |
| 8 | Vanguard Global Advisers#8 · 3,321 sh | 3,321 | $21.9K | 0.00% | 0.0% |
| 9 | MORGAN STANLEY#9 · 3,000 sh | 3,000 | $19.8K | 0.00% | +200.0% |
| 10 | OSAIC#10 · 1,900 sh | 1,900 | $12.5K | 0.00% | New |
| 11 | ROYAL BANK OF CANADA#11 · 658 sh | 658 | $4.0K | 0.00% | +46.9% |
| 12 | OF TOLEDO NA#12 · 352 sh | 352 | $2.3K | — | 0.0% |
| 13 | ACTION POINT FINANCIAL PLANNING#13 · 159 sh | 159 | $1.0K | <0.01% | New |
| 14 | UBS Group AG#14 · 139 sh | 139 | $917.00 | 0.00% | -99.1% |
| 15 | SBI Securities , Ltd.#15 · 69 sh | 69 | $455.00 | — | -2.8% |
| 16 | BARCLAYS PLC#16 · 26 sh | 26 | $172.00 | 0.00% | New |
| 17 | Steward Partners Investment Advisory#17 · 10 sh | 10 | $66.00 | 0.00% | 0.0% |
| 18 | BNP PARIBAS FINANCIAL MARKETS#18 · 9 sh | 9 | $59.00 | 0.00% | 0.0% |
| 19 | WELLS FARGO & COMPANY#19 · 5 sh | 5 | $33.00 | 0.00% | 0.0% |
| 20 | Caitong International Asset Management , Ltd#20 · 2 sh | 2 | $13.00 | 0.00% | +100.0% |
| 21 | JPMORGAN CHASE#21 · 1 sh | 1 | $7.00 | 0.00% | 0.0% |
Funds that sold out of DRIO in Q2 2026 (2)
Held DRIO at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Tower Research Capital (TRC)448 sh | 448 | $3.6K |
| CITIGROUP1 sh | 1 | $8.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.